{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:48:20Z","timestamp":1782524900713,"version":"3.54.5"},"reference-count":111,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.diabet.2012.02.006","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T19:44:44Z","timestamp":1334259884000},"page":"281-289","source":"Crossref","is-referenced-by-count":36,"title":["Peripheral neuropathy in children with type 1 diabetes"],"prefix":"10.1016","volume":"38","author":[{"given":"M.","family":"Louraki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Karayianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Kanaka-Gantenbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Katsalouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Karavanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2012.02.006_bib0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2298\/SARH0508358S","article-title":"Subclinical peripheral neuropathy in type 1 diabetic adolescents and its relationship with metabolic control","volume":"133","author":"Sajic","year":"2005","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.diabet.2012.02.006_bib0010","first-page":"422","article-title":"Complications of childhood diabetes and the role of technology","volume":"7","author":"Cho","year":"2010","journal-title":"Pediatr Endocrinol Rev."},{"key":"10.1016\/j.diabet.2012.02.006_bib0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00467-010-1624-9","article-title":"Microvascular disease in children and adolescents with type 1 diabetes and obesity","volume":"26","author":"Marcovecchio","year":"2011","journal-title":"Pediatr Nephrol."},{"key":"10.1016\/j.diabet.2012.02.006_bib0020","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2337\/diab.15.6.411","article-title":"Peripheral neuropathy in juvenile diabetes","volume":"15","author":"Gamstorp","year":"1966","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2012.02.006_bib0025","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1515\/JPEM.2005.18.11.1087","article-title":"High prevalence of diabetic polyneuropathy in a group of Brazilian children with type 1 diabetes mellitus","volume":"18","author":"Nery Ferreira","year":"2005","journal-title":"J Pediatr Endocrinol Metab."},{"key":"10.1016\/j.diabet.2012.02.006_bib0030","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.2337\/diab.46.2.S54","article-title":"Classification, differential diagnosis, and staging of diabetic peripheral neuropathy","volume":"46","author":"Thomas","year":"1997","journal-title":"Diabetes."},{"key":"10.1016\/j.diabet.2012.02.006_bib0035","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/diacare.28.4.956","article-title":"Diabetic neuropathies: a statement by the American Diabetes Association","volume":"28","author":"Boulton","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0040","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1212\/WNL.43.4.817","article-title":"The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study","volume":"43","author":"Dyck","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.diabet.2012.02.006_bib0045","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1399-5448.2009.00636.x","article-title":"A 5-yr follow-up nerve conduction study for the detection of subclinical diabetic neuropathy in children with newly diagnosed insulin-dependent diabetes mellitus","volume":"11","author":"Lee","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabet.2012.02.006_bib0050","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1515\/JPEM.1999.12.3.411","article-title":"Prevalence of microvascular and neurologic abnormalities in a population of diabetic children","volume":"12","author":"Karavanaki","year":"1999","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.diabet.2012.02.006_bib0055","series-title":"Diabetes mellitus: A Fundamental and clinical text, 2nd edition","first-page":"910","article-title":"Diabetic neuropathies. An overview of clinical aspects, pathogenesis and treatment","author":"Vinik","year":"2000"},{"key":"10.1016\/j.diabet.2012.02.006_bib0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00275940","article-title":"Free and lipid inositol, sorbitol, and sugars in sciatic nerve obtained post-mortem from diabetic patients and control subjects","volume":"24","author":"Mayhew","year":"1983","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2012.02.006_bib0065","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.2337\/diabetes.42.12.1737","article-title":"Mechanisms for D-glucose inhibition of myo-inositol influx into rat lens","volume":"42","author":"Mistry","year":"1993","journal-title":"Diabetes."},{"key":"10.1016\/j.diabet.2012.02.006_bib0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7326\/0003-4819-101-4-527","article-title":"Nonenzymatic glycosylation and the pathogenesis of diabetic complications","volume":"101","author":"Browlee","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabet.2012.02.006_bib0075","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2337\/diabetes.34.6.553","article-title":"Recognition and uptake of human diabetic peripheral nerve myelin by macrophages","volume":"34","author":"Vlassara","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2012.02.006_bib0080","first-page":"389","article-title":"New trends in the etiopathogenesis of diabetic peripheral neuropathy","volume":"16","author":"Verrotti","year":"2001","journal-title":"J Child Neurol"},{"key":"10.1016\/j.diabet.2012.02.006_bib0085","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1172\/JCI18058","article-title":"Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily","volume":"114","author":"Bierhaus","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabet.2012.02.006_bib0090","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","article-title":"Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB","volume":"50","author":"Bierhaus","year":"2001","journal-title":"Diabetes."},{"key":"10.1016\/j.diabet.2012.02.006_bib0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02780555","article-title":"Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes","volume":"6","author":"McLean","year":"1992","journal-title":"Mol Neurobiol."},{"key":"10.1016\/j.diabet.2012.02.006_bib0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/brain\/awg029","article-title":"Inflammatory vasculopathy in multifocal diabetic neuropathy","volume":"126","author":"Said","year":"2003","journal-title":"Brain."},{"key":"10.1016\/j.diabet.2012.02.006_bib0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/10623329709079870","article-title":"Neurovascular [125I]-ET-1 binding sites on human peripheral nerve","volume":"5","author":"Dashwood","year":"1997","journal-title":"Endothelium."},{"key":"10.1016\/j.diabet.2012.02.006_bib0110","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.metabol.2003.12.002","article-title":"The relationship between glycemic control and plasma vascular endothelial growth factor and endothelin-1 concentration in diabetic patients","volume":"53","author":"Kakizawa","year":"2004","journal-title":"Metabolism."},{"key":"10.1016\/j.diabet.2012.02.006_bib0115","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1399-543X.2004.00041.x","article-title":"Diabetic neuropathy in children and adolescents (Review)","volume":"5","author":"Trotta","year":"2004","journal-title":"Pediatric Diabetes"},{"key":"10.1016\/j.diabet.2012.02.006_bib0120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1464-5491.1995.tb00478.x","article-title":"Nitric oxide as a potential bridge between the metabolic and vascular hypothesis of diabetic neuropathy","volume":"12","author":"Stevens","year":"1995","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2012.02.006_bib0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00592-003-0123-x","article-title":"Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study","volume":"40","author":"Strokov","year":"2003","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabet.2012.02.006_bib0130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2310\/6650.2006.06009","article-title":"Abnormal levels of serum antielastin antibodies in children with diabetes mellitus type 1","volume":"54","author":"Nicoloff","year":"2006","journal-title":"J Investig Med"},{"key":"10.1016\/j.diabet.2012.02.006_bib0135","first-page":"845","article-title":"Peripheral diabetic neuropathy and polyunsaturated fatty acid supplementations: natural sources or biotechnological needs?","volume":"50","author":"Coste","year":"2004","journal-title":"Cell Mol Biol."},{"key":"10.1016\/j.diabet.2012.02.006_bib0140","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0169-328X(02)00652-6","article-title":"Abnormal PI3 kinase\/Akt signal pathway in vagal afferent neurons and vagus nerve of streptozotocin-diabetic rats","volume":"110","author":"Cai","year":"2003","journal-title":"Brain Res Mol Brain Res."},{"key":"10.1016\/j.diabet.2012.02.006_bib0145","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/brain\/awg150","article-title":"Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3","volume":"126","author":"Middlemas","year":"2003","journal-title":"Brain."},{"key":"10.1016\/j.diabet.2012.02.006_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/bmb\/ldp053","article-title":"Prevention and treatment of microvascular disease in childhood type 1 diabetes","volume":"94","author":"Marcovecchio","year":"2010","journal-title":"Br Med Bull."},{"key":"10.1016\/j.diabet.2012.02.006_bib0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2337\/diacare.10.4.441","article-title":"Small and large fibre involvement in early diabetic neuropathy: A study with the median plantar response and sensory thresholds","volume":"10","author":"Levy","year":"1987","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0160","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0026-0495(83)80024-9","article-title":"Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function","volume":"32","author":"Greene","year":"1983","journal-title":"Metabolism"},{"key":"10.1016\/j.diabet.2012.02.006_bib0165","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.2337\/dc10-0456","article-title":"Low peripheral nerve conduction velocities and amplitudes are strongly related to diabetic microvascular complications in type 1 diabetes: the EURODIAB Prospective Complications Study","volume":"33","author":"Charles","year":"2010","journal-title":"Diabetes Care."},{"key":"10.1016\/j.diabet.2012.02.006_bib0170","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ncpendmet0142","article-title":"Diabetic neuropathies: clinical manifestations and current treatment options","volume":"2","author":"Vinik","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab."},{"key":"10.1016\/j.diabet.2012.02.006_bib0175","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2337\/diacare.29.04.06.dc05-2180","article-title":"The relationship among pain, sensory loss, and small nerve fibers in diabetes","volume":"29","author":"Sorensen","year":"2006","journal-title":"Diabetes Care."},{"key":"10.1016\/j.diabet.2012.02.006_bib0180","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/jnnp.51.11.1420","article-title":"Evaluation of thermal, pain and vibration sensation thresholds in newly diagnosed type 1 diabetic patients","volume":"51","author":"Ziegler","year":"1988","journal-title":"J Neurol Psychiatr"},{"key":"10.1016\/j.diabet.2012.02.006_bib0185","series-title":"Diabetic neuropathy","first-page":"27","article-title":"Epidemiology","author":"Melton","year":"1987"},{"key":"10.1016\/j.diabet.2012.02.006_bib0190","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/jnnp.56.5.509","article-title":"Subclinical diabetic polyneuropathy: early detection of involvement of different nerve fibre types","volume":"56","author":"Hendriksen","year":"1993","journal-title":"J Neurol Neuros Psyc"},{"key":"10.1016\/j.diabet.2012.02.006_bib0195","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.23.4.510","article-title":"Patterns of Quantitative Sensation Testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy","volume":"23","author":"Dyck","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0200","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0924-980X(98)00017-4","article-title":"Subclinical neuropathy in type I diabetic children","volume":"109","author":"Meh","year":"1998","journal-title":"Electroencephalogr Clin Neurophysiol."},{"key":"10.1016\/j.diabet.2012.02.006_bib0205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jdiacomp.2008.12.009","article-title":"The diabetic hand: a forgotten complication?","volume":"24","author":"Papanas","year":"2010","journal-title":"J Diabetes Complications."},{"key":"10.1016\/j.diabet.2012.02.006_bib0210","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2337\/diacare.11.7.592","article-title":"Report and recommendations of San Antonio Conference on diabetic neuropathy: American Diabetes Association\/American Academy of Neurology","volume":"11","author":"Consensus Statement","year":"1988","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0215","series-title":"Electrodiagnosis in disease of nerve and muscle: principles and practice","author":"Kimura","year":"1989"},{"key":"10.1016\/j.diabet.2012.02.006_bib0220","series-title":"Diabetic neuropathy","first-page":"162","article-title":"Electrophysiologic testing in diabetic neuropathy","author":"Daube","year":"1987"},{"key":"10.1016\/j.diabet.2012.02.006_bib0225","first-page":"131","article-title":"Evaluation of asymptomatic central neuropathy in type I diabetes mellitus","volume":"46","author":"Uzun","year":"2006","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"10.1016\/j.diabet.2012.02.006_bib0230","first-page":"269","article-title":"Comparison of the sensitivities of plantar nerve conduction techniques for early detection of diabetic sensory polyneuropathy","volume":"50","author":"Hemmi","year":"2010","journal-title":"Electromyogr Clin Neurophysiol."},{"key":"10.1016\/j.diabet.2012.02.006_bib0235","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.21661","article-title":"Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: clinical vs. neurophysiological trial","volume":"42","author":"Dyck","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.diabet.2012.02.006_bib0240","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.clinph.2004.01.003","article-title":"Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children","volume":"115","author":"Turgut","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.diabet.2012.02.006_bib0245","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/mus.10181","article-title":"Small-fiber neuropathy","volume":"26","author":"Lacomis","year":"2002","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.diabet.2012.02.006_bib0250","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/diacare.20.9.1448","article-title":"The use of biothesiometry to detect neuropathy in children and adolescents with IDDM","volume":"20","author":"Davis","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0255","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1399-5448.2006.00208.x","article-title":"Comparison of conventional and non-invasive techniques for the early identification of diabetic neuropathy in children and adolescents with type 1 diabetes","volume":"7","author":"Nelson","year":"2006","journal-title":"Ped Diab"},{"key":"10.1016\/j.diabet.2012.02.006_bib0260","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.2337\/dc10-0616","article-title":"Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT\/EDIC study","volume":"33","author":"Martin","year":"2010","journal-title":"Diabetes Care."},{"key":"10.1016\/j.diabet.2012.02.006_bib0265","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diacare.24.2.250","article-title":"Simple screening tests for peripheral neuropathy in the diabetes clinic","volume":"24","author":"Perkins","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0270","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2337\/diacare.27.10.2386","article-title":"Thermal thresholds predict painfulness of diabetic neuropathies","volume":"27","author":"Kramer","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0275","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0887-8994(98)00141-6","article-title":"Prevalence of peripheral neuropathy with insulin-dependent diabetes mellitus","volume":"20","author":"Bao","year":"1999","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.diabet.2012.02.006_bib0280","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1515\/JPEM.2006.19.1.45","article-title":"Early diabetic complications in a population of young patients with T1DM despite intensive treatment","volume":"19","author":"Nordwall","year":"2006","journal-title":"J Ped End Met"},{"key":"10.1016\/j.diabet.2012.02.006_bib0285","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/BF02723816","article-title":"Nerve conduction in children suffering insulin dependent diabetes mellitus","volume":"70","author":"Cenesiz","year":"2003","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.diabet.2012.02.006_bib0290","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.2337\/dc10-0616","article-title":"Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT\/EDIC study","volume":"33","author":"Martin","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0295","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2337\/diacare.11.6.481","article-title":"Specific assessments of warm and cool sensitivities in adult diabetic patients","volume":"11","author":"Sosenko","year":"1988","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0300","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1056-8727(00)00078-7","article-title":"A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. Danish Study Group of Diabetes in Childhood","volume":"14","author":"Olsen","year":"2000","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabet.2012.02.006_bib0305","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1464-5491.2002.00793.x","article-title":"Subclinical pain and thermal sensory dysfunction in children and adolescents with Type 1 diabetes mellitus","volume":"19","author":"Abad","year":"2002","journal-title":"Diabetic Med"},{"key":"10.1016\/j.diabet.2012.02.006_bib0310","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11892-001-0010-1","article-title":"Complications of pediatric and adolescent type 1 diabetes mellitus","volume":"1","author":"Brink","year":"2001","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.diabet.2012.02.006_bib0315","first-page":"90","article-title":"A better future for children with type 1 diabetes: review of the conclusions from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications study","volume":"106","author":"Morales","year":"2009","journal-title":"J Ark Med Soc."},{"key":"10.1016\/j.diabet.2012.02.006_bib0320","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-3476(81)80954-7","article-title":"Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control","volume":"99","author":"White","year":"1981","journal-title":"J Paediatr"},{"key":"10.1016\/j.diabet.2012.02.006_bib0325","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in IDDM","volume":"329","author":"The Diabetes Control Complications Trial Research group.","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2012.02.006_bib0330","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2337\/diacare.24.4.748","article-title":"Glycemic control is related to the morphological severity of diabetic sensorimotor polyneuropathy","volume":"24","author":"Perkins","year":"2001","journal-title":"Diabetes Care."},{"key":"10.1016\/j.diabet.2012.02.006_bib0335","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jdiacomp.2005.11.002","article-title":"Bedside neuropathy disability score compared to quantitative sensory testing for measurement of diabetic neuropathy in children, adolescents, and young adults with type 1 diabetes","volume":"21","author":"Weintrob","year":"2007","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabet.2012.02.006_bib0340","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1651-2227.1997.tb09023.x","article-title":"Nerve conduction and autonomic nerve function in diabetic children. A 10-year follow-up study","volume":"86","author":"Solders","year":"1997","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.diabet.2012.02.006_bib0345","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1399-5448.2009.00636.x","article-title":"A 5-yr follow-up nerve conduction study for the detection of subclinical diabetic neuropathy in children with newly diagnosed insulin-dependent diabetes mellitus","volume":"11","author":"Lee","year":"2010","journal-title":"Pediatr Diabetes."},{"key":"10.1016\/j.diabet.2012.02.006_bib0350","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0355","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1096-9136(199803)15:3<228::AID-DIA551>3.0.CO;2-8","article-title":"Peripheral sensory nerve dysfunction in children and adolescents with type 1 diabetes mellitus","volume":"15","author":"Barkai","year":"1998","journal-title":"Diabetes Med"},{"key":"10.1016\/j.diabet.2012.02.006_bib0360","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2337\/diacare.8.6.605","article-title":"The vibratory perception threshold in young diabetic patients: associations with glycaemia and puberty","volume":"8","author":"Sosenko","year":"1985","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0365","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0404.1988.tb03634.x","article-title":"Neuropathy in children and adolescents with diabetes mellitus","volume":"78","author":"Gallai","year":"1988","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.diabet.2012.02.006_bib0370","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/diabetes.37.4.476","article-title":"Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of diabetes control and complications trial (DCCT)","volume":"37","author":"The DCCT Research Group","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2012.02.006_bib0375","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/bmj.288.6433.1793","article-title":"Use of a biothesiometer to measure individual vibration thresholds and their variation in 519 non-diabetic subjects","volume":"288","author":"Bloom","year":"1984","journal-title":"BMJ"},{"key":"10.1016\/j.diabet.2012.02.006_bib0380","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.diabres.2004.07.017","article-title":"The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed T1DM","volume":"67","author":"Karsidag","year":"2005","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/j.diabet.2012.02.006_bib0385","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1651-2227.1979.tb18449.x","article-title":"Sensory nerve conduction velocity and vibratory sensibility in Juvenile Diabetics","volume":"68","author":"Ludvigsson","year":"1979","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/j.diabet.2012.02.006_bib0390","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1210\/jc.2007-1185","article-title":"Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes","volume":"92","author":"Monti","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.diabet.2012.02.006_bib0395","first-page":"108A","article-title":"Diabetes-induced increases in vascular permeability are prevented by castration and by sorbinil (abstract)","volume":"34","author":"Williamson","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2012.02.006_bib0400","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2337\/diacare.14.5.386","article-title":"Role of height and glycosylated hemoglobin in abnormal nerve conduction in pediatric patients with T1DM after 4-9 Yr of disease","volume":"14","author":"Duck","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0405","first-page":"35","article-title":"Childhood diabetic neuropathy: a clinical and electrophysiological study","volume":"15","author":"el Bahri-Ben Mrad","year":"2000","journal-title":"Funct Neurol."},{"key":"10.1016\/j.diabet.2012.02.006_bib0410","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2337\/diacare.23.7.1044","article-title":"Puberty as a risk factor for diabetic neuropathy","volume":"23","author":"Barkai","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0415","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJM198409133111102","article-title":"Muscle capillary basement membrane thickness and long-term glycaemia in type 1 diabetes mellitus","volume":"31","author":"Sosenko","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2012.02.006_bib0420","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM198309013090904","article-title":"Insulin-like growth factors: studies in diabetics with and without retinopathy","volume":"309","author":"Merimee","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2012.02.006_bib0425","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.2337\/diacare.24.6.1087","article-title":"Peripheral nerve function is increasingly impaired during puberty in adolescents with type 1 diabetes","volume":"24","author":"Riihimaa","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2012.02.006_bib0430","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.2337\/diacare.28.8.1974","article-title":"Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002","volume":"28","author":"Mohsin","year":"2005","journal-title":"Diabetes Care."},{"key":"10.1016\/j.diabet.2012.02.006_bib0435","first-page":"109","article-title":"Neuropathy and type 1 diabetes mellitus","volume":"14","author":"Otto-Buczkowska","year":"2008","journal-title":"Pediatr Endocrinol Diabetes Metab."},{"key":"10.1016\/j.diabet.2012.02.006_bib0440","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1464-5491.1999.00024.x","article-title":"Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus","volume":"16","author":"Olsen","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2012.02.006_bib0445","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2337\/diabetes.32.2.142","article-title":"Nerve function and metabolic control in teenage diabetics","volume":"32","author":"Young","year":"1983","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2012.02.006_bib0450","first-page":"380","article-title":"Screening for subclinical complications in young type 1 diabetic patients: experience acquired in Brussels","volume":"1","author":"Dorchy","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.diabet.2012.02.006_bib0455","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-3476(81)80954-7","article-title":"Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control","volume":"99","author":"White","year":"1981","journal-title":"J Pediatrics"},{"key":"10.1016\/j.diabet.2012.02.006_bib0460","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp.65.5.620","article-title":"Diabetes mellitus and the nervous system","volume":"65","author":"Watkins","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.diabet.2012.02.006_bib0465","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11892-001-0024-8","article-title":"Treatments for diabetic neuropathy","volume":"1","author":"Boulton","year":"2001","journal-title":"Curr Diab Rep."},{"key":"10.1016\/j.diabet.2012.02.006_bib0470","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/SPC.0b013e32832b7df5","article-title":"Advances in the management of diabetic peripheral neuropathy","volume":"3","author":"Tesfaye","year":"2009","journal-title":"Curr Opin Support Palliat Care."},{"issue":"5 Suppl.","key":"10.1016\/j.diabet.2012.02.006_bib0475","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0885-3924(03)00067-8","article-title":"Rationale and evidence for the use of oxcarbazepine in neuropathic pain","volume":"25","author":"Carrazana","year":"2003","journal-title":"J Pain Symptom Manage."},{"issue":"6","key":"10.1016\/j.diabet.2012.02.006_bib0480","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1533-2500.2011.00450.x","article-title":"Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin","volume":"11","author":"Gore","year":"2011","journal-title":"Pain Pract"},{"key":"10.1016\/j.diabet.2012.02.006_bib0485","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1056-8727(00)00060-X","article-title":"Maintenance of the long term efficacy of tramadol for the treatment of the pain of diabetic neuropathy","volume":"14","author":"Harati","year":"2000","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabet.2012.02.006_bib0490","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1900\/RDS.2009.6.230","article-title":"Alpha-lipoic acid and diabetic neuropathy","volume":"6","author":"Vallianou","year":"2009","journal-title":"Rev Diabet Stud."},{"key":"10.1016\/j.diabet.2012.02.006_bib0495","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1464-5491.2004.01109.x","article-title":"Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis","volume":"21","author":"Ziegler","year":"2004","journal-title":"Diabet Med."},{"key":"10.1016\/j.diabet.2012.02.006_bib0500","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2337\/dc06-1216","article-title":"Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial","volume":"29","author":"Ziegler","year":"2006","journal-title":"Diabetes Care."},{"issue":"Suppl. 1","key":"10.1016\/j.diabet.2012.02.006_bib0505","first-page":"A2","article-title":"Effect of 4-year antioxidant treatment with a-lipoic acid in diabetic polyneuropathy: the NATHAN 1 trial","volume":"56","author":"Ziegler","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2012.02.006_bib0510","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/(SICI)1096-9136(199612)13:12<1017::AID-DIA252>3.0.CO;2-Z","article-title":"A meta-analysis of trials on aldose reductase inhibitors in diabetic peripheral neuropathy. The Italian Study Group. The St.-Vincent Declaration","volume":"13","author":"Nicolucci","year":"1996","journal-title":"Diabet Med."},{"key":"10.1016\/j.diabet.2012.02.006_bib0515","first-page":"154","article-title":"Diabetic neuropathy in childhood: review","volume":"12","author":"Donaghue","year":"1999","journal-title":"Diabetes Nutr Metab."},{"key":"10.1016\/j.diabet.2012.02.006_bib0520","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/138161208784139774","article-title":"Role of advanced glycation end products in diabetic neuropathy","volume":"14","author":"Sugimoto","year":"2008","journal-title":"Curr Pharm Des."},{"key":"10.1016\/j.diabet.2012.02.006_bib0525","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/S0140-6736(98)02478-7","article-title":"Effects of the angiotensin-converting enzyme inhibitor trandanopril on human diabetic neuropathy: a randomized controlled trial","volume":"352","author":"Malik","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.diabet.2012.02.006_bib0530","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/dmrr.541","article-title":"Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes","volume":"21","author":"Kamiya","year":"2005","journal-title":"Diabetes Metab Res Rev."},{"key":"10.1016\/j.diabet.2012.02.006_bib0535","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.2337\/diabetes.53.6.1556","article-title":"Molecular alterations underlie nodal and paranodal degeneration in type 1 diabetic neuropathy and are prevented by C-peptide","volume":"53","author":"Sima","year":"2004","journal-title":"Diabetes."},{"key":"10.1016\/j.diabet.2012.02.006_bib0540","first-page":"343","article-title":"Peripheric and automatic neuropathy in children with type 1 diabetes mellitus: the effect of L-carnitine treatment on the peripheral and autonomic nervous system","volume":"45","author":"Uzun","year":"2005","journal-title":"Electromyogr Clin Neurophysiol."},{"issue":"8","key":"10.1016\/j.diabet.2012.02.006_bib0545","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","article-title":"Activation of protein kinase C isoforms and its impact on diabetic complications","volume":"106","author":"Geraldes","year":"2010","journal-title":"Circ Res."},{"issue":"5","key":"10.1016\/j.diabet.2012.02.006_bib0550","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1476-5381.2011.01272.x","article-title":"Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats","volume":"164","author":"Liu","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.diabet.2012.02.006_bib0555","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/JPR.S15452","article-title":"Pharmacological evaluation of rat dorsal root ganglion neurons as an in vitro model for diabetic neuropathy","volume":"14","author":"Peeraer","year":"2011","journal-title":"J Pain Res."}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363612000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363612000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T06:01:13Z","timestamp":1561615273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363612000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1262363612000420"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2012.02.006","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}